Alaunos Therapeutics | ZIOP - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Alaunos Therapeutics USD 447K 138K 2026-03
Amgen USD 1.72B 134M 2026-06
AstraZeneca USD 5.8B 735M 2026-06
Baxter International USD 735M 7M 2026-06
Biogen USD 709.7M 155.4M 2026-06
Bioline Rx USD 858K 257K 2026-03
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Celltrion KRW 9.32B 3.39B 2026-03
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Curis USD 2.96M 1.62M 2026-03
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.19B 75M 2026-06
Incyte USD 351.73M 23.64M 2026-06
Intrexon USD 10.31M 41K 2024-06
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
J&J USD 6.42B 381M 2026-06
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Karyopharm Therapeutics USD 10.42M 861K 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Merck USD 2.89B 219M 2026-06
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Novartis USD 3.24B 101M 2026-06
Organigram Holdings CAD 22.01M 14.28M 2026-03
Ovoca Bio EUR 617K 15K 2025-12
Pfizer USD 3.41B 496M 2026-06
Pharma Mar EUR 17.12M 1.82M 2026-06
PTC Therapeutics USD 73.89M 13.31M 2026-03
Qiagen NV USD 142.33M 60K 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sartorius EUR 221.3M 0 2026-06
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
TG Therapeutics USD 62.32M 10.82M 2026-06
Tilray USD 24.85M 1.7M 2025-09
Verastem USD 22.3M 2.14M 2026-03
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 223.14M 8.82M 2026-06